Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02932956
Title Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Patients With Pediatric Solid Tumors (GAP)
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Baylor College of Medicine
Indications

liver cancer

Advanced Solid Tumor

Therapies

Cyclophosphamide + Fludarabine

Anti-GPC3-scFvGC33-CAR autologous T Lymphocytes

Age Groups: adult | child
Covered Countries USA


No variant requirements are available.